Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran

Acinetobacter baumannii is one of the most important opportunistic challenging pathogens as a result of its ability to acquire resistance to broad range of antibiotics and cause a variety of severe nosocomial infections. We investigated the frequency of the aminoglycoside-modifying enzymes (AMEs) an...

Full description

Bibliographic Details
Main Authors: S.M. Mortazavi, Z. Farshadzadeh, S. Janabadi, M. Musavi, F. Shahi, M. Moradi, S. Khoshnood
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:New Microbes and New Infections
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2052297520301311
_version_ 1818389629360930816
author S.M. Mortazavi
Z. Farshadzadeh
S. Janabadi
M. Musavi
F. Shahi
M. Moradi
S. Khoshnood
author_facet S.M. Mortazavi
Z. Farshadzadeh
S. Janabadi
M. Musavi
F. Shahi
M. Moradi
S. Khoshnood
author_sort S.M. Mortazavi
collection DOAJ
description Acinetobacter baumannii is one of the most important opportunistic challenging pathogens as a result of its ability to acquire resistance to broad range of antibiotics and cause a variety of severe nosocomial infections. We investigated the frequency of the aminoglycoside-modifying enzymes (AMEs) and oxacillinase genes among clinical isolates of A. baumannii collected from hospitalized patients in Imam Khomeini Hospital, Ahvaz city, Iran. This prospective cross-sectional study was performed on 80 clinical isolates of A. baumannii collected from patients referred to Imam Khomeini Hospital in Ahvaz, Iran. Initial identification of isolates as A. baumannii was performed using conventional bacteriologic tests, and final confirmation was carried out by PCR of blaOXA-51-like gene and multiplex PCR of gyrB locus. MICs of different classes of antibiotics against these strains was measured by using VITEK 2 system. After extraction of genomic DNA, two groups of multidrug-resistant A. baumannii genes including AME (aadA1, aadB, aphA6 and aacC1) and oxacillinases (blaOXA-23-like, blaOXA-24-like, blaOXA-51-like, blaOXA-58-like and blaOXA-143-like) were detected. According to antibiotic susceptibility testing, among 80 A. baumannii strains, 75 isolates (91.25%) were multidrug resistant. The results showed that colistin and tigecycline, with respective sensitivity rates of 97.5% (78/80) and 56.25% (45/80), had the highest effects. The presence of blaOXA-51-like and gyrB genes was confirmed in all strains. Furthermore, blaOXA-23-like and blaOXA-24-like genes were found in 68.75% (55/80) and 20% (16/80) of isolates respectively, while no isolate harbored the blaOXA-143-like gene. The frequency of genes encoding the AMEs including aadA1, aacC1, aphA6 and aadB were 11.25% (9/80), 16.25% (13/80), 22.5% (18/80) and 30% (24/80) respectively. Our findings indicate that the presence of the aadB and aphA6 is correlated with high resistance against amikacin and gentamicin. We found a very high resistance rate against most of the antimicrobial agents usually prescribed for severe infections caused by A. baumannii. Therefore, because of rapid emergence of resistance even for colistin or tigecycline, monotherapy should be avoided. These results show the importance of providing antibiotics correctly in intensive care units and following antibiotic stewardship protocols as the only effective strategies to attempt to control antibiotic resistance in healthcare settings.
first_indexed 2024-12-14T04:44:46Z
format Article
id doaj.art-1e0102fdb9a04c56a6f3d3a29c43bb30
institution Directory Open Access Journal
issn 2052-2975
language English
last_indexed 2024-12-14T04:44:46Z
publishDate 2020-11-01
publisher Elsevier
record_format Article
series New Microbes and New Infections
spelling doaj.art-1e0102fdb9a04c56a6f3d3a29c43bb302022-12-21T23:16:42ZengElsevierNew Microbes and New Infections2052-29752020-11-0138100779Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west IranS.M. Mortazavi0Z. Farshadzadeh1S. Janabadi2M. Musavi3F. Shahi4M. Moradi5S. Khoshnood6Student Research Committee, School of Medicine, Bam University of Medical Sciences, Bam, IranInfectious and Tropical Diseases Research Center, Health Research Institute, Iran; Health Research Institute of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranDepartment of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IranStudent Research Committee, School of Medicine, Bam University of Medical Sciences, Bam, IranInfectious and Tropical Diseases Research Center, Health Research Institute, Iran; Health Research Institute of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranInfectious and Tropical Diseases Research Center, Health Research Institute, Iran; Health Research Institute of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranStudent Research Committee, School of Medicine, Bam University of Medical Sciences, Bam, Iran; Corresponding author: S. Khoshnood, Student Research Committee, School of Medicine, Bam University of Medical Sciences, Bam, Iran.Acinetobacter baumannii is one of the most important opportunistic challenging pathogens as a result of its ability to acquire resistance to broad range of antibiotics and cause a variety of severe nosocomial infections. We investigated the frequency of the aminoglycoside-modifying enzymes (AMEs) and oxacillinase genes among clinical isolates of A. baumannii collected from hospitalized patients in Imam Khomeini Hospital, Ahvaz city, Iran. This prospective cross-sectional study was performed on 80 clinical isolates of A. baumannii collected from patients referred to Imam Khomeini Hospital in Ahvaz, Iran. Initial identification of isolates as A. baumannii was performed using conventional bacteriologic tests, and final confirmation was carried out by PCR of blaOXA-51-like gene and multiplex PCR of gyrB locus. MICs of different classes of antibiotics against these strains was measured by using VITEK 2 system. After extraction of genomic DNA, two groups of multidrug-resistant A. baumannii genes including AME (aadA1, aadB, aphA6 and aacC1) and oxacillinases (blaOXA-23-like, blaOXA-24-like, blaOXA-51-like, blaOXA-58-like and blaOXA-143-like) were detected. According to antibiotic susceptibility testing, among 80 A. baumannii strains, 75 isolates (91.25%) were multidrug resistant. The results showed that colistin and tigecycline, with respective sensitivity rates of 97.5% (78/80) and 56.25% (45/80), had the highest effects. The presence of blaOXA-51-like and gyrB genes was confirmed in all strains. Furthermore, blaOXA-23-like and blaOXA-24-like genes were found in 68.75% (55/80) and 20% (16/80) of isolates respectively, while no isolate harbored the blaOXA-143-like gene. The frequency of genes encoding the AMEs including aadA1, aacC1, aphA6 and aadB were 11.25% (9/80), 16.25% (13/80), 22.5% (18/80) and 30% (24/80) respectively. Our findings indicate that the presence of the aadB and aphA6 is correlated with high resistance against amikacin and gentamicin. We found a very high resistance rate against most of the antimicrobial agents usually prescribed for severe infections caused by A. baumannii. Therefore, because of rapid emergence of resistance even for colistin or tigecycline, monotherapy should be avoided. These results show the importance of providing antibiotics correctly in intensive care units and following antibiotic stewardship protocols as the only effective strategies to attempt to control antibiotic resistance in healthcare settings.http://www.sciencedirect.com/science/article/pii/S2052297520301311Acinetobacter baumanniiaminoglycoside resistance genescarbapenem-resistant A. baumannii (CRAB)multidrug resistance (MDR)oxacillinase genes
spellingShingle S.M. Mortazavi
Z. Farshadzadeh
S. Janabadi
M. Musavi
F. Shahi
M. Moradi
S. Khoshnood
Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran
New Microbes and New Infections
Acinetobacter baumannii
aminoglycoside resistance genes
carbapenem-resistant A. baumannii (CRAB)
multidrug resistance (MDR)
oxacillinase genes
title Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran
title_full Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran
title_fullStr Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran
title_full_unstemmed Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran
title_short Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran
title_sort evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of acinetobacter baumannii from ahvaz south west iran
topic Acinetobacter baumannii
aminoglycoside resistance genes
carbapenem-resistant A. baumannii (CRAB)
multidrug resistance (MDR)
oxacillinase genes
url http://www.sciencedirect.com/science/article/pii/S2052297520301311
work_keys_str_mv AT smmortazavi evaluatingthefrequencyofcarbapenemandaminoglycosideresistancegenesamongclinicalisolatesofacinetobacterbaumanniifromahvazsouthwestiran
AT zfarshadzadeh evaluatingthefrequencyofcarbapenemandaminoglycosideresistancegenesamongclinicalisolatesofacinetobacterbaumanniifromahvazsouthwestiran
AT sjanabadi evaluatingthefrequencyofcarbapenemandaminoglycosideresistancegenesamongclinicalisolatesofacinetobacterbaumanniifromahvazsouthwestiran
AT mmusavi evaluatingthefrequencyofcarbapenemandaminoglycosideresistancegenesamongclinicalisolatesofacinetobacterbaumanniifromahvazsouthwestiran
AT fshahi evaluatingthefrequencyofcarbapenemandaminoglycosideresistancegenesamongclinicalisolatesofacinetobacterbaumanniifromahvazsouthwestiran
AT mmoradi evaluatingthefrequencyofcarbapenemandaminoglycosideresistancegenesamongclinicalisolatesofacinetobacterbaumanniifromahvazsouthwestiran
AT skhoshnood evaluatingthefrequencyofcarbapenemandaminoglycosideresistancegenesamongclinicalisolatesofacinetobacterbaumanniifromahvazsouthwestiran